The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of GSK PLC GSK dropped 1.59% to £13.92 Tuesday, on what proved to be an all-around poor trading session for the stock ...

GSK market cap is currently £55.9B and has a P/E ratio of 22.22. Based on the recent corporate insider activity of 333 insiders, corporate insider sentiment is positive on the stock. This means that ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV ...

Several companies such as Shriram Finance, Symphony, etc. will be in focus today on account of corporate actions.

GSK bought into the EOS-448 programme last year in a deal orchestrated by its chief scientific officer Hal Barron, who is leaving to join biotech startup Altos at the beginning of August.

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

In case you missed it, biotech analyst Brian Skorney and industry veteran Daphne Zohar joined “The Readout Loud,” STAT’s ...

The highest price of Glaxosmithkline Pharmaceuticals Ltd stock is ₹3,088.00 in the last 52-week. What is the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) today on NSE? As on Nov 08 ...